首页> 外文期刊>European geriatric medicine. >Re-evaluation of prognostic significance of NT-proBNP in a 5-year follow-up study assessing all-cause mortality in elderly patients (?? 75 years) admitted to hospital due to suspect heart failure
【24h】

Re-evaluation of prognostic significance of NT-proBNP in a 5-year follow-up study assessing all-cause mortality in elderly patients (?? 75 years) admitted to hospital due to suspect heart failure

机译:在一项为期5年的随访研究中对NT-proBNP的预后意义进行了重新评估,该研究评估了因可疑心衰入院的老年患者(≥75岁)的全因死亡率

获取原文
获取原文并翻译 | 示例
           

摘要

Background: N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a prognostic biomarker in heart failure (HF), especially in younger population. The prognostic value of NT-proBNP in an elderly HF population (?? 75 years) remains less studied. The purpose of this study is to evaluate the prognostic value of NT-proBNP in patients aged ?? 75 years and admitted to hospital due to suspect HF with a median follow-up of 5 years. Methods: A prospective hospital cohort of 243 patients (82 ?? 4 years) who had NT-proBNP analyzed due to suspect HF during 2005-2007 was studied. Results: Among the study population, 75% had acute decompensated HF. Multivariable Cox proportional-hazard regression analysis and univariable Kaplan-Meier survival analysis demonstrated that NT-proBNP was not prognostic significant in HF cohort ?? 75 years old, and instead, pulmonary hypertension, history of valvular surgery and use of aldosterone receptor antagonist were significant prognostic indicators. However, subgroup analysis showed that in patients with NT-proBNP levels > 8000 (ng/L), NT-proBNP is the only significant independent indicator for 5-year mortality whereas in patients with NT-proBNP ?? 8000 (ng/L), enlargement of left atrium and pulmonary hypertension, instead of NT-proBNP, were significant prognostic indicators for mortality. Conclusion: In a HF population ?? 75 years old with acute decompensated HF, NT-proBNP was not significant prognostic indicator, except in a subgroup with NT-proBNP > 8000 (ng/L). Therefore, the prognostic value of NT-proBNP in those HF patients ?? 75 years has to be interpreted with caution due to higher age and comorbidity. Crown
机译:背景:N端前B型利钠肽(NT-proBNP)是心力衰竭(HF)的预后生物标志物,尤其是在年轻人群中。 NT-proBNP在老年HF人群(≥75岁)中的预后价值尚待研究。这项研究的目的是评估NT-proBNP在??患者中的预后价值。 75年,因怀疑心衰而入院,平均随访5年。方法:对2005-2007年间因疑似HF进行NT-proBNP分析的243例患者(82〜4岁)的前瞻性医院队列进行了研究。结果:在研究人群中,有75%的人患有急性失代偿性HF。多变量Cox比例风险回归分析和单变量Kaplan-Meier生存分析表明,NT-proBNP在HF队列中的预后并不显着。 75岁的患者,而是肺动脉高压,瓣膜手术史和使用醛固酮受体拮抗剂是重要的预后指标。但是,亚组分析显示,NT-proBNP水平> 8000(ng / L)的患者,NT-proBNP是5年死亡率的唯一重要独立指标,而NT-proBNP≥25 8000(ng / L),左心房增大和肺动脉高压代替NT-proBNP是死亡率的重要预后指标。结论:在HF人群中? 75岁的急性失代偿性HF患者中,NT-proBNP> 8000(ng / L)的亚组除外,不是显着的预后指标。因此,NT-proBNP在那些HF患者中的预后价值?由于年龄较大和合并症,必须谨慎解释75岁。王冠

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号